April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
-
-
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral renal denervation ...
-
November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of ...
-
November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023 (AHA 2023), which compared the effects of high-sodium and low-sodium ...
Mar. 10, 2025-- Corcept Therapeutics Inc., a commercial-stage company engaged in the discovery and development of ...
March 11, 2025
At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., Medtronic presented new data and ...
March 10, 2025
Jan. 13, 2025 — Medtronic recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...
January 27, 2025
Jan. 9, 2025 — Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and beyond ...
January 14, 2025
Jan. 13, 2025 — Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...
January 14, 2025
Jan. 8, 2025 — Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines ...
January 08, 2025
Dec. 11, 2024 — Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking ...
December 19, 2024
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...
July 10, 2024
June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...
June 28, 2024
June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...
June 20, 2024
Study: Young Athletes at Risk for Elevated Blood Pressure Rates, Future Cardiovascular Complications
June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at ...
June 06, 2024
May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced ...
May 16, 2024
May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...
May 08, 2024
May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...
May 06, 2024
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...
April 07, 2024